Eloxx Pharmaceuticals Valuation
| ELOXDelisted Stock | USD 6.12 0.30 4.67% |
At this time, the firm appears to be overvalued. Eloxx Pharmaceuticals shows a prevailing Real Value of $5.67 per share. The current price of the firm is $6.12. Our model computes the value of Eloxx Pharmaceuticals from reviewing the firm fundamentals such as Shares Owned By Insiders of 0.59 %, current valuation of 30.28 M, and Shares Owned By Institutions of 37.06 % as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Eloxx Pharmaceuticals' price fluctuation is very steady at this time. Calculation of the real value of Eloxx Pharmaceuticals is based on 3 months time horizon. Increasing Eloxx Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Eloxx Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Eloxx Pink Sheet. However, Eloxx Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6.12 | Real 5.67 | Hype 6.12 | Naive 4.61 |
The intrinsic value of Eloxx Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Eloxx Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Eloxx Pharmaceuticals helps investors to forecast how Eloxx pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Eloxx Pharmaceuticals more accurately as focusing exclusively on Eloxx Pharmaceuticals' fundamentals will not take into account other important factors: Eloxx Pharmaceuticals Total Value Analysis
Eloxx Pharmaceuticals is currently estimated to have valuation of 30.28 M with market capitalization of 14.86 M, debt of 13.38 M, and cash on hands of 30.05 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Eloxx Pharmaceuticals fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
30.28 M | 14.86 M | 13.38 M | 30.05 M |
Eloxx Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of Eloxx is to check how much profit was generated for every dollar of assets it reports. Eloxx Pharmaceuticals shows a negative utilization of assets of -0.73 percent, losing $0.007318 for each dollar of assets held by the firm. Inadequate asset utilization denotes the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Eloxx Pharmaceuticals shows how discouraging it operates for each dollar spent on its assets.Eloxx Pharmaceuticals Ownership Allocation
The market capitalization of Eloxx Pharmaceuticals is $14.86 Million. 30% of Eloxx Pharmaceuticals outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Eloxx Pharmaceuticals Profitability Analysis
Net Loss for the year was (36.06 M) with profit before overhead, payroll, taxes, and interest of 0.About Eloxx Pharmaceuticals Valuation
Our relative valuation model uses a comparative analysis of Eloxx Pharmaceuticals. We calculate exposure to Eloxx Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Eloxx Pharmaceuticals's related companies.Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Eloxx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Watertown, Massachusetts. Eloxx Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 28 people.
8 Steps to conduct Eloxx Pharmaceuticals' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Eloxx Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Eloxx Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Eloxx Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Eloxx Pharmaceuticals' revenue streams: Identify Eloxx Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Eloxx Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Eloxx Pharmaceuticals' growth potential: Evaluate Eloxx Pharmaceuticals' management, business model, and growth potential.
- Determine Eloxx Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Eloxx Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Eloxx Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 2.2 M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Eloxx Pink Sheet
If you are still planning to invest in Eloxx Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eloxx Pharmaceuticals' history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |